The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bergmann, C. C.
Right arrow Articles by Stohlman, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bergmann, C. C.
Right arrow Articles by Stohlman, S. A.
The Journal of Immunology, 2001, 167: 1575-1583.
Copyright © 2001 by The American Association of Immunologists

Impaired T Cell Immunity in B Cell-Deficient Mice Following Viral Central Nervous System Infection1

Cornelia C. Bergmann2,*,{dagger}, Chandran Ramakrishna*, Margaret Kornacki* and Stephen A. Stohlman*,{ddagger}

Departments of * Neurology, {dagger} Pathology, and {ddagger} Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
CD8+ T cells are required to control acute viral replication in the CNS following infection with neurotropic coronavirus. By contrast, studies in B cell-deficient (µMT) mice revealed Abs as key effectors in suppressing virus recrudescence. The apparent loss of initial T cell-mediated immune control in the absence of B cells was investigated by comparing T cell populations in CNS mononuclear cells from infected µMT and wild-type mice. Following viral recrudescence in µMT mice, total CD8+ T cell numbers were similar to those of wild-type mice that had cleared infectious virus; however, virus-specific T cells were reduced at least 3-fold by class I tetramer and IFN-{gamma} ELISPOT analysis. Although overall T cell recruitment into the CNS of µMT mice was not impaired, discrepancies in frequencies of virus-specific CD8+ T cells were most severe during acute infection. Impaired ex vivo cytolytic activity of µMT CNS mononuclear cells, concomitant with reduced frequencies, implicated IFN-{gamma} as the primary anti viral factor early in infection. Reduced virus-specific CD8+ T cell responses in the CNS coincided with poor peripheral expansion and diminished CD4+ T cell help. Thus, in addition to the lack of Ab, limited CD8+ and CD4+ T cell responses in µMT mice contribute to the ultimate loss of control of CNS infection. Using a model of virus infection restricted to the CNS, the results provide novel evidence for a role of B cells in regulating T cell expansion and differentiation into effector cells.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The CD8+ T cells comprise a dominant component in the resolution of many primary viral infections. However, chronic stimulation, especially under conditions of high Ag load, can lead to down-regulation of effector function, anergy, and ultimately Ag-specific CD8+ T cell exhaustion (1, 2, 3). Regulatory interactions involving CD4+ T cells, B cells, and Ig can delay the exhaustion process by providing help and/or by reducing Ag load. Thus, both the CD4+ T cell and humoral immune compartment play an active role in determining the outcomes of CD8+ T cell function ranging from complete viral clearance to uncontrolled viral replication concomitant with functional exhaustion (1, 2, 3, 4, 5, 6, 7, 8).

The contribution of B cells and Ig in viral clearance as well as activation and maintenance of Ag-specific CD4+ and CD8+ T cells has been studied in several viral infection models using C57BL/6-Igh-6tm1Cgm B cell-deficient (µMT) (3) mice (7, 9, 10, 11, 12, 13, 14, 15, 16, 17). These mice lack mature B220+ cells and consequently both germinal center formation and the ability to secrete Ig (9). Trapping of Ag-Ab immune complexes on follicular dendritic cells potentially maintaining T cell memory is thereby abrogated. However, no differences in viral replication or clearance were observed comparing infection of µMT and wild-type (wt)3 mice with lymphocytic choriomeningitis virus (LCMV), influenza virus, or murine cytomegalovirus (7, 8, 10, 11, 14). CD8+ T cell function appeared to be independent of B cells during numerous acute infections (7, 8, 10, 13). Furthermore, the CD8+ memory population remained stable in the absence of B cells or Ab following viral clearance (10, 13), and immune µMT mice effectively clear challenge virus (10, 15). Similarly, the frequency of CD4+ T cells was not altered significantly during acute influenza virus infection nor in the memory phase comparing wt and µMT mice (11). Thus, for these primary viral infections, CD8+ and CD4+ T cell activation and memory were independent of B cells.

By contrast, B cells and/or Ab play a critical role in controlling recrudescence and spread of viruses establishing persistent or latent infections (7, 13, 14, 17, 18, 19, 20). Uncontrolled LCMV infection in µMT mice is associated with CD8+ T cell exhaustion, similar to high-dose exhaustion in wt mice (8, 13). Furthermore, LCMV immune T cells from µMT mice adoptively transferred into LCMV-infected recipients were less efficient in clearing infectious virus compared with immune splenocytes from wt mice (16). Despite containing similar frequencies of Ag-specific T cells, splenocytes from immune µMT mice had a reduced capacity to secrete both IL-2 and IFN-{gamma}, suggesting impaired T cell effector function (16). Contrasting the majority of data implicating no role of B cells in T cell expansion and differentiation, the latter data suggested that B cells do participate in the generation and maintenance of fully competent CD4+ and CD8+ T cells during systemic LCMV infection.

Infection with the neurotropic JHM strain (JHMV) of mouse hepatitis virus provides a model of localized infection in which the absence of B cells results in uncontrolled, persistent CNS infection despite initial viral reduction by T cells (17). In wt mice, a potent regional CD8+ T cell response is sufficient to completely eliminate infectious virus from the CNS (21, 22, 23, 24). There is little mortality and the clinical symptoms of disease partially resolve following acute infection (25, 26). Nevertheless, viral Ag and RNA persist exclusively within the CNS (25, 27, 28). Persistence is associated with ongoing demyelination, but little or no clinical abnormalities, thus providing a model for the human demyelinating disease multiple sclerosis (25, 26). Humoral immune responses were thought to play a minor role based on observations that infectious virus is eliminated from the CNS before detection of neutralizing anti-viral Ab (29). Consistent with a primary role of cell-mediated immunity in controlling acute JHMV replication, infectious virus declines with similar kinetics in JHMV-infected µMT and wt mice (17). However, in contrast to wt mice, infectious virus recrudesces in the CNS of µMT mice following initial control of replication. Concomitant with virus reactivation, clinical symptoms continue to worsen and the majority of mice succumb to infection by days 30–45 postinfection (p.i.). Importantly, passive transfer of polyclonal anti-JHMV Ab, but not control Ab from naive mice, following initial clearance prevents virus reactivation (17). These data suggest that although T cell-mediated immunity is sufficient to reduce infectious virus during acute disease, immunological control is not maintained in the absence of humoral immunity.

Recrudescence of infectious virus in µMT mice could not be associated with selection of CTL escape variants nor an apparent loss of T cells in the CNS by immunohistological examination (17). However, decreased CD8+ T cell cytotoxicity from splenocytes of recrudescing µMT mice (17) suggested the possibility of CD8+ T cell anergy or exhaustion. To explore the mechanisms underlying the inability of T cells to control persistent CNS infection in the absence of humoral immunity, CNS mononuclear cells (CMC) from infected mice were examined for the frequency and function of virus-specific T cells. Although total CMC CD8+ populations were similar in magnitude in µMT and wt mice, class I tetramer analysis revealed reduced numbers of CD8+ T cells specific for the immunodominant S510 epitope throughout the entire disease course in µMT mice. Lower numbers of virus-specific CD8+ T cells in the CNS coincided with impaired expansion in the periphery and was linked to reduced frequencies of virus-specific CD4+ T cells. The results further indicate that while minimal T cell responses initially suffice to control CNS infection, viral replication outruns T cell replenishment, potentially leading to peripheral T cell exhaustion. Compared with other well-described viral infections of µMT mice (7, 8, 10, 11, 13), limited CD4+ and CD8+ T cell function apparent during the primary response appears to be unique to infection of the CNS. Consistent with recent evidence of impaired function of LCMV-specific memory T cells primed in the absence of B cells (16), the present findings thus provide direct support for a role of B cells in regulating CD8+ T cells directly or via CD4+ T cells in a model of viral infection confined to the CNS.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Mice, viruses, and CD4 depletion

Male C57BL/6 (H-2b) mice were purchased from the National Cancer Institute (Frederick, MD) at 6 wk of age and certified naive to prior mouse hepatitis virus exposure. µMT mice, obtained as breeding pairs from The Jackson Laboratory (C57BL/6-Igh-6tm1Cgn; Bar Harbor, ME), were bred at the University of Southern California Keck School of Medicine under pathogen-free conditions. Mice were housed in microisolator cages in an accredited animal facility at the University of Southern California and infected at 6–7 wk of age. CNS infections were induced by intracranial injection of 30 µl containing 200–500 PFU of the 2.2v-1 mAb-derived variant of JHMV as previously described (30). This variant produces paralysis associated with demyelination and replicates predominantly in oligodendrocytes. Virus was propagated in the presence of neutralizing mAb J.2.2 and quantified by plaque assay using monolayers of the murine delayed brain tumor astrocytoma cell line (17). Intraperitoneal injections were conducted with 4 x 106 PFU of the parental JHMV isolate designated DM variant (31).

Mice were depleted of CD4+ T cells by i.p. injection of 250 µg of anti-CD4 mAb GK1.5 at days -2, 0, and +2 relative to virus infection as described elsewhere (22, 32); control mice received PBS injections at the same time points. This treatment resulted in >98% depletion of CD4+ T cells at day 8 p.i. as analyzed by flow cytometry.

Tissue sampling and isolation of lymphocytes

CMC were obtained from pooled brains and spinal cords of 6–10 mice/group at various time points p.i. as described previously (33, 34). Briefly, tissues were minced and homogenized in Tenbrock homogenizers. Cell suspensions were adjusted to 30% Percoll (Pharmacia, Uppsala, Sweden) and concentrated onto a 70% Percoll cushion by centrifugation at 800 x g at 4°C for 20 min, washed, and resuspended in RPMI 1640 medium. Yields varied from 0.8 to 2.0 x 106 cells/mouse, with maximum yields between days 8 and 12 p.i. Single-cell suspensions were prepared from the spleens and cervical lymph nodes (CLN) from identical groups of mice as previously described (35).

CTL assays and synthetic peptides

CTL assays were performed as described elsewhere (24, 36). Briefly, EL-4 (H-2b) target cells were labeled with 100 µCi of Na51CrO4 (New England Nuclear, Boston, MA) and S510 peptide was added to washed target cells at a final concentration of 1 µM before addition of CTL at the indicated E:T ratios. Supernatants (100 µl) were removed after 4 h of incubation and specific 51Cr release was determined. Specific lysis was defined as 100 x (experimental release - spontaneous release)/(detergent release - spontaneous release). Maximum spontaneous release values were <10% of the total release values.

The Db-restricted S510 peptide (37, 38) was synthesized by the University of Southern California Norris Cancer Center Microchemistry Laboratory and purity assessed by HPLC and mass spectrometry. The I-Ab-restricted M133 peptide (39) was purchased from Genemed Synthesis (South San Francisco, CA). Peptides were solubilized at 1 mM in DMSO and diluted in sterile PBS.

ELISPOT assays

ELISPOT assays to measure the frequency of Ag-specific IFN-{gamma}-secreting cells were conducted as described previously (24). Serial 2.5-fold dilutions of cells were plated in triplicate into 96-well plates supporting cellulose ester membranes (MultiScreen HA; Millipore, Bedford, MA) precoated with R4-6A2 mAb (BD PharMingen, San Diego, CA) and stimulated in the presence of irradiated (25 Gy) splenocytes from naive mice (5 x 105/well), either pulsed with 1 µM class I-restricted S510 peptide, class II-restricted M133 peptide, or left untreated. EL-4 supernatant was added as a source of IL-2 to a final concentration of 2.5%. Cultures were incubated for 36 h at 37°C. Bound IFN-{gamma} was detected by overnight incubation at 4°C with biotinylated anti-IFN-{gamma} mAb (0.5 µg/ml, XMG1.2; BD PharMingen), followed by consecutive incubations with streptavidin-peroxidase (Sigma, St. Louis, MO) and 3,3'-diaminobenzidine as substrate (Sigma).

Flow cytometry

Single-cell suspensions were blocked with purified anti-mouse CD16/CD32 (2.4G2; BD PharMingen) and stained with FITC-, PE-, or CyChrome-conjugated mAb specific for CD8 (7), CD4 (GK1.5), CD62L (MEL-14), CD43 (1B11), CD44 (IM7), CD69 (H1.2F3), CD25 (PC61), CD11a (2D7), CD49d (R1-2; BD PharMingen), and PE-conjugated Db-S510 tetramer (0.1–0.2 µg/0.5–1.0 x 106 cells) in various combinations. Cells were typically stained at 4°C with mAb for 15–20 min before incubation with tetramer for 30 min in PBS containing 0.1% BSA. The generation of Db-S510 tetramers, composed of Db class I H chains, {beta}2-microglobulin, and the S510 peptide, was previously described (24). Samples were analyzed by flow cytometry on a FACStar (BD Biosciences, Mountain View, CA). Forward and side scatter signals obtained in linear mode were used to establish a gate that contained intact lymphocytes, while excluding remaining tissue debris. A minimum of 4 x 105 viable cells were stained and 5 x 104–1 x 105 events were analyzed per sample.

Synthesis of intracellular IFN-{gamma} in response to Ag stimulation was determined by incubating 4–5 x 105 CMC or 1 x 106 splenocytes in 100 µl of RPMI 1640 complete supplemented with 10% FCS, 1 µM peptide, and 1 µg/ml monensin (BD PharMingen) for 5 h at 37°C (3). Peptide was omitted in negative control samples. Cells were then stored at 4°C overnight and stained 14–16 h later using the Cytofix/Cytosperm kit (BD PharMingen). Following surface staining, cells were fixed, permeabilized, and stained with mAb specific for IFN-{gamma} (XMG1.2) as recommended by the supplier (BD PharMingen).


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Reduced Ag-specific CD8+ T cell responses within the CNS of µMT mice

Previous studies of acute JHMV infection in µMT mice suggested that T cell responses within the CNS were comparable to those in wt mice (17). This interpretation was based on 1) similar kinetics of initial virus clearance, 2) no apparent differences in the number of CNS infiltrating CD8+ or CD4+ T cells determined by immunohistochemistry, and 3) similar CTL responses of in vitro-restimulated splenocytes harvested at day 7 p.i. However, the inability of µMT mice to control the infection beyond day 10 p.i. implied that T cells were rendered unresponsive and/or underwent activation-induced cell death due to increasing viral load. To assess the possibility of CD8+ T cell exhaustion, the frequencies of CD8+ T cells specific for the immunodominant S510 epitope were determined at times when virus has been cleared from the CNS of wt mice, but re-emerged in µMT mice (17). CMC from wt and µMT-infected mice were initially analyzed at days 14 and 21 p.i. by flow cytometry and IFN-{gamma} ELISPOT assay (Fig. 1Go). The percentage of total CD8+ T cells in CMC was similar or elevated in µMT mice (Fig. 1GoA), consistent with immunohistochemical analysis (17). Nevertheless, as determined by tetramer staining, the population of virus-specific cells within the CD8+ T cell compartment never exceeded 12% in µMT-derived CMC, whereas it ranged between 30 and 40% in wt-derived CD8+ CMC (Fig. 1GoA). Consistent with a relative decrease in tetramer staining cells, the frequencies of CD8+ T cells secreting IFN-{gamma} at day 14 p.i. were at least 3-fold lower in µMT- compared with wt-derived CMC (Fig. 1GoB). In wt mice, frequencies of IFN-{gamma}-secreting cells further declined by day 21 p.i., consistent with the decline in viral Ag (17). Decreased frequencies of IFN-{gamma}-secreting CD8+ T cells were also evident in CMC from µMT mice, despite viral recrudescence. This confirmed an inability to respond to increasing virus load and suggested either limited resources of peripheral Ag-specific T cells to replenish the CNS, inhibited infiltration, down-regulation of type 1 CD8+ T cell effector function, or a combination of these factors.



View larger version (37K):
[in this window]
[in a new window]
 
FIGURE 1. Reduced frequencies of S510-specific CD8+ T cells during viral recrudescence in the CNS of µMT mice. CMC were prepared from JHMV-infected mice at 14 and 21 days p.i. (n = 7–8 per time point). A, CMC were stained for expression of CD8 (FITC-labeled anti-CD8) and S510 epitope-specific TCR using PE-labeled Db-S510 tetramers. Percentages of CD8+ T cells within CMC are depicted by boxes (left y-axis) and percentages of tetramer+ cells within the CD8 population by circles (right y-axis); {blacksquare}, wt CMC; , µMT CMC. Data from two representative experiments of four, designated a and b, are shown. B, The frequency of cells responding to S510-coated feeder splenocytes was measured by IFN-{gamma} ELISPOT. Numbers of cells secreting IFN-{gamma} in response to peptide stimulation were determined within a linear range and standardized to 1 x 106 unfractionated cells. Cells secreting IFN-{gamma} in the absence of peptide were subtracted. Error bars, SD of three to six wells.

 
Previous analysis indicated no difference in numbers and distribution of apoptotic cells in the CNS of wt vs µMT mice (17). Significantly reduced frequencies of S510-specific CD8+ T cells in µMT mice following initial control of viral replication could thus not be attributed to enhanced apoptosis. To uncover potential defects in induction or recruitment of virus-specific CD8+ T cells in µMT mice, CMC were analyzed at early times p.i. (Fig. 2Go). At day 5 p.i., percentages of total CD8+ T cells were higher in CMC from µMT mice, suggesting that T cell recruitment into the CNS was not impaired in µMT mice; tetramer+ cells within the CMC population of either group were below detection limits at this time (Fig. 2GoA). Surprisingly however, at day 8 p.i., when viral clearance was similar in both groups (17), CD8+ T cells within CMC derived from µMT mice only contained 4–9% tetramer+ cells, whereas CD8+ T cells from wt mice typically contained 33% tetramer+ cells (Fig. 2GoA). Despite similar overall CD8+ T cell infiltration, tetramer+ cells constituted a significantly reduced percentage within the CNS of µMT mice compared with wt mice. Overall yields of CMC from either infected group ranged from 1.5 to 2.0 x 106/mouse during acute infection, and differences never exceeded 25% between the groups. These data implied that few of the CD8+ T cells recruited into the CNS of JHMV-infected µMT mice are indeed S510 specific or, alternatively, TCR down-regulation due to high stimulation. Frequencies of S510-specific IFN-{gamma}-secreting cells were also at least 3-fold lower in µMT-derived CMC (Fig. 2GoB), confirming reduced numbers of S510-specific T cells at the functional level. Nevertheless, similar or lower ratios of tetramer+ to IFN-{gamma}-secreting CD8+ T cells in CMC from µMT mice compared with wt mice suggests that µMT-derived CD8+ T cells are not inherently impaired in cytokine-mediated effector function.



View larger version (38K):
[in this window]
[in a new window]
 
FIGURE 2. Reduced frequencies of S510-specific CD8+ T cells during CNS infection of µMT mice. CMC of infected mice were prepared at 5 and 8 days p.i. (n = 7–8 per time point) and analyzed as described in the legend to Fig. 1Go. A, CMC were stained with anti-CD8 mAb and Db-S510 tetramers. Data from two experiments, a and b, representative of four to five experiments are shown. B, The frequency of cells responding to S510-coated feeder splenocytes was measured by IFN-{gamma} ELISPOT. Ratios of tetramer+:IFN-{gamma}-secreting cells are indicated above each bar at day 8 p.i.

 
A reduction of S510-specific CD8+ T cells at day 8 p.i. was not anticipated due to effective virus clearance up to day 10 p.i., suggesting that few virus-specific CD8+ T cells suffice to mediate strong antiviral effector function. However, direct examination of this notion revealed very poor ex vivo cytolytic activity of µMT-derived CMC at day 8 p.i. compared with wt CMC (Fig. 3Go). Even when E:T ratios were adjusted to reflect only tetramer+ CD8+ T cells, cytolysis on a per cell basis was severely reduced. Furthermore, re-emerging viral replication did not trigger increased cytolytic activity (Fig. 3Go). Thus, similar to wt mice (24), CNS-resident CD8+ T cells in µMT mice were rendered noncytolytic after initial viral reduction. These data support IFN-{gamma} secretion as a major antiviral mechanism (23), as this function did not appear impaired on a per cell basis (Fig. 2Go) in contrast to cytolytic function (Fig. 3Go).



View larger version (22K):
[in this window]
[in a new window]
 
FIGURE 3. Impaired cytolytic activity of CMC from µMT mice. CMC were prepared from infected wt and µMT mice (n = 6–8) at 8, 14, and 21 days p.i. Ex vivo cytotoxicity was assayed at the indicated E:T ratios using EL-4 cells coated with 1 µM S510 peptide. Background cytolysis of untreated target cells was <5% and subtracted from specific lysis of peptide-coated targets. E:T ratios are presented based on total populations (proximal to axis marks) or percentage of tetramer+ cells determined by flow cytometric analysis (circles). Data are representative of two independent assays.

 
Phenotypic comparisons of CD8+ CMC derived from acutely infected µMT and wt mice revealed similar expression patterns of activation/memory markers (Table IGo). The majority of CNS-infiltrating CD8+ T cells at day 8 p.i. were CD44high and CD62-, CD11ahigh and CD49d+, characteristic of an activated/memory phenotype (40). However, µMT-derived CMC consistently contained slightly increased populations of naive CD8+ T cells characterized by the CD44low/int and CD62high, CD11alow, and CD49d- phenotype. CD69 and CD25 expression were similar or slightly elevated on the CD8+ populations of µMT-derived CMC (Table IGo); no differences in CD69 or CD25 expression was evident in CD4+ T cells derived from either CMC group (~21–23% CD69+ and 15–16% CD25+; data not shown). The only distinct difference between µMT and wt mice was a reduced frequency of CD43highCD8+ T cells reaching only 43% in µMT CD8+ populations, compared with 76% in wt CD8+ T cells (Table IGo). CD43 up-regulation has recently been identified as marking cytolytic CD8+ T cells (41). Phenotypic analysis thus confirmed poor cytolysis exhibited by µMT-derived CMC rather than potential heterologous responses to other viral epitopes.


View this table:
[in this window]
[in a new window]
 
Table I. Phenotypic analysis of CMC-derived CD8+ T cells1

 
Impaired peripheral CD8+ T cell expansion in infected µMT mice

To determine whether reduced frequencies of virus-specific CD8+ T cells in the CNS coincided with reduced numbers in the periphery, splenocytes and CLN T cells were analyzed for S510-specific TCR expression and S510-induced IFN-{gamma} secretion at days 5 and 8 p.i. Tetramer+ CD8+ T cells were readily detectable in the spleen and CLN of wt mice, but were severely reduced in µMT mice, despite higher CD8+ T cell percentages arising from the lack of B cells (Fig. 4GoA). Analysis of CMC from the same groups of mice confirmed accumulation of Ag-specific cells specifically at the site of infection. These data suggested that reduced S510-specific CD8+ T cells in the CNS of µMT mice resulted from impaired peripheral expansion following CNS infection. Consistent with these data, the frequency of IFN-{gamma}-secreting S510-specific CD8+ T cells in both spleens and CLN was 2- to 3-fold lower in µMT mice (Fig. 4GoB). However, each group of mice revealed discrepancies between tetramer staining and ELISPOT analysis. Although splenocytes of wt mice contained higher frequencies of tetramer+ T cells than CLN, the frequency of IFN-{gamma}-secreting cells was higher in the CLN. This inability to detect tetramer+ cells may reside in down-regulation of TCR due to more potent Ag-specific stimulation in the CLN. The same observation was made in µMT mice, despite overall lower frequencies of IFN-{gamma}-secreting cells at both sites. Enhanced frequencies of IFN-{gamma}-secreting cells in the CLN compared with spleen were already pronounced at day 5 p.i., when tetramer+ cells were below detection. These data thus support CLN as the primary site of T cell priming in both wt and µMT mice during CNS infection, as suggested for CNS infection induced by LCMV (42). The lack of higher frequencies of virus-specific CD8+ T cells in the spleen of wt mice compared with µMT mice at day 5 p.i. further indicates that sequestration of virus-natural Ab immune complexes to the spleen (43) plays a minor role in T cell priming in this model of infection.



View larger version (34K):
[in this window]
[in a new window]
 
FIGURE 4. Expansion of virus-specific CD8+ T cells in peripheral lymphoid organs. A, Spleen (SPL) and CLN cells, as well as CMC, obtained from µMT and wt mice at day 8 p.i. were stained for expression of CD8 (FITC-labeled anti CD8; x-axis) and S510 epitope-specific TCR (PE-labeled Db-S510 tetramer as indicated; y-axis). Density plots of cells from wt mice are shown in the left column, cells from µMT mice in the right column. Numbers in each quadrant represent percentages of the total population. Plots are representative of three separate determinations. B, Splenocytes and CLN cells obtained from mice at 5 and 8 days p.i. stained with anti-CD8 mAb and Db-S510 tetramer. Percentages of total CD8+ T cells are depicted by bars (left y-axis). Percentages of Db-S510 tetramer+ cells within the CD8+ population are depicted by circles (right y-axis). C, The frequency of cells responding to peptide-coated feeder splenocytes was measured by IFN-{gamma} ELISPOT as described in the legend to Fig. 1Go; cells were derived from the same groups of mice analyzed in B. Data are representative of three separate experiments.

 
Impaired CD8+ T cell responses are associated with reduced CD4+ T cell activation

For some viral infections, CD8+ T cell expansion, function, and survival is tightly linked to the CD4+ T cell compartment (22, 44, 45, 46, 47). During acute JHMV infection, survival and function of CD8+ T cells in the CNS, but not entry, is dependent on CD4+ T cells (22). Furthermore, CD4+ T cells appear to enhance peripheral CD8+ T cell expansion, as indicated by decreased cytolytic activity of splenocytes from infected mice depleted of CD4+ T cells (22). ELISPOT analysis was therefore used to analyze expansion of CD4+ T cells specific for the dominant M133 epitope located within the viral matrix protein (39). At day 8 p.i., both splenocytes and CMC from µMT mice contained severely reduced frequencies of IFN-{gamma}-secreting CD4+ T cells (Fig. 5Go). Reduced frequencies of M133-specific CD4+ T cells in the CNS, despite similar total CD4+ populations, again implied a defect in virus-specific CD4+ T cell expansion rather than recruitment, similar to CD8+ T cell expansion. This was indeed supported by the low frequencies of splenic virus-specific CD4+ T cells. Reduced CD8+ T cell responses in µMT mice following JHMV infection may thus be a direct consequence of impaired CD4+ T cell expansion, rather than a CD8+ T cell-specific defect.



View larger version (32K):
[in this window]
[in a new window]
 
FIGURE 5. Expansion of virus-specific CD4+ T cells in µMT mice. CMC and splenocytes obtained from infected wt and µMT mice (n = 6–8 per group) at day 8 p.i. were analyzed for the frequency of CD4+ T cells responding to the dominant viral matrix protein-derived M133 peptide. Splenocytes from wt mice coated with 1 µM peptide were used as feeder cells. Frequencies of IFN-{gamma}-secreting cells were calculated as described in the legend to Fig. 1Go. Total percentages of CD4+ T cells (right y-axis) are shown by circles for reference. Data are representative of three independent assays.

 
To confirm a role of CD4+ Th function for JHMV-specific CD8+ T cell expansion, wt mice were depleted of CD4+ T cells before infection. CMC from CD4-depleted and mock-depleted infected wt mice were compared with infected µMT mice for production of IFN-{gamma} by peptide-stimulated CD8+ T cells (Fig. 6Go). Intracellular IFN-{gamma} staining revealed that CD4+ T cell depletion reduced the frequency of S510-responsive CD8+ T cells to 60% of that in untreated wt mice. However, only 4% of CD8+ T cells from µMT mice produced IFN-{gamma} following stimulation; this represents only 19% of the wt value. Nevertheless, the mean fluorescence intensities of IFN-{gamma}+ cells from µMT and CD4-depleted mice were only slightly reduced, indicating no significant impairment in IFN-{gamma} production. These data suggest that although CD4+ T cells enhance CD8+ T cell responses during JHMV infection, deprivation of CD4+ T cell help alone does suffice to account for the impaired CD8+ T cell response in µMT mice. Transfer of 2.5 x 107 splenic B cells from naive wt mice into µMT mice a day before infection did not affect priming/expansion of either CD4+ or CD8+ T cells (data not shown). There were no differences in the frequencies of S510 CD8+ T cells or M133 CD4+ T cells at 5 or 8 days p.i. in either the spleen, CLN, or CNS. However, CD19+ B cells only comprised 1–2% in splenic or CLN populations at the time of T cell analysis. The inability to rescue T cell expansion presumably resides in the previously reported rapid disappearance of B cells from µMT recipients (48). Thus, unlike other peripheral infections studied in µMT mice (10, 11, 12, 13, 14, 15), T cell priming and expansion following infection of the CNS appears to require the physical presence of B cells and/or a B cell-dependent component absent in µMT mice.



View larger version (31K):
[in this window]
[in a new window]
 
FIGURE 6. Contribution of CD4+ T cells to CD8+ T cell effector function within the CNS. The wt mice were depleted of CD4+ T cells and their CD8+ T cell response compared with mock-treated wt and µMT mice at day 8 p.i. CMC from all three groups were stimulated with 1 µM S510 peptide for 5 h using endogenous APC as feeders. Production of intracellular IFN-{gamma} was measured in the CD8+ population by flow cytometric analysis. Numbers in each quadrant represent percentages of the total population. Numbers in parentheses, percentages of IFN-{gamma}+ cells in the CD8+ T cell population. Mean fluorescent intensities (MFI) of IFN-{gamma}+ cells are indicated. Dot plots are representative of three separate determinations.

 
To evaluate whether decreased T cell priming in µMT mice is correlated to CNS infection, a more virulent, parental JHMV was administered i.p. This route of administration results in an asymptomatic infection associated with limited replication, but effective T cell priming in wt mice. At day 8 after peripheral immunization, splenocytes of µMT mice revealed severely decreased expansion of S510-specific CD8+ T cells compared with wt mice (Fig. 7Go). Percentages of both tetramer+ and IFN-{gamma}-producing cells in the CD8+ population were reduced at least 5-fold in µMT mice. These data confirm a role of B cells in priming CD8+ T cell responses to JHMV, independent of the complexities associated with the lack of CNS lymphatic drainage (42, 49, 50).



View larger version (53K):
[in this window]
[in a new window]
 
FIGURE 7. Ag-specific CD8+ T cell expansion is impaired following peripheral immunization. Splenocytes from wt and µMT mice (n = 3–4) injected with 4 x 106 PFU i.p. were prepared at day 8 p.i. and mock stimulated (-; first and second row) or stimulated with 1 µM S510 peptide (+; third row) for 5 h using endogenous APC as feeders. Production of intracellular IFN-{gamma} was measured as described in the legend to Fig. 6Go. Cells not containing peptide were stained with tetramer (top row) to assess ratios of IFN-{gamma}+ relative to tetramer+ cells. Relative to the percentage of tetramer+ CD8+ T cells (top row), 31% of S510-specific cells from µMT mice secreted IFN-{gamma} compared with 34% from wt mice (bottom row). Dot plots are representative of two separate determinations.

 
Reduced absolute T cell numbers compromise control of infection in µMT mice

The effects of impaired Ag-specific CD8+ T cell expansion in µMT mice are compounded by reduced cellularity of both CLN and spleen (11). Although relative percentages of CD4+ and CD8+ T cells are increased, cell yields of CLN and spleen per mouse in JHMV-infected µMT mice at day 8 p.i. were typically 2- to 3- and 4- to 6-fold reduced compared with wt mice, respectively. Because tetramer+ cells were below detection limits in spleen and CLN after d 8 p.i. in both wt and µMT mice, frequencies of S510-specific IFN-{gamma}-secreting T cells were used to calculate S510-responding T cells per spleen to adjust for the reduced cellularity in µMT mice throughout the course of infection (Fig. 8Go). A reduction of splenic S510-specific CD8+ T cells in µMT mice was most dramatic on day 8 p.i., but was evident throughout the infection in µMT mice; at day 21 p.i., the frequency of S510-specific IFN-{gamma} spots was below 1 in 106 splenocytes (Fig. 8Go). This supports the notion that few available circulating memory cells may lead to CD8+ T cell exhaustion, even when chronic Ag stimulation is confined to the CNS. These data suggest that in addition to the lack of Ab, inefficient CD8+ T cell expansion and concomitant exhaustion may contribute to viral recrudescence within the CNS of µMT mice.



View larger version (28K):
[in this window]
[in a new window]
 
FIGURE 8. Reduction of virus-specific CD8 T cells compound incomplete viral clearance. Splenocytes were prepared from infected mice (n = 4–6) at days 5, 8, 14, and 21 p.i. The frequency of cells responding to S510 peptide-coated splenocytes was measured by IFN-{gamma} ELISPOT as described in the legend to Fig. 1Go, and total numbers are calculated per spleen. Total yields of splenocytes are provided for reference (right y-axis, circles).

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Acute viral infections generally elicit both cellular and humoral immune responses. Selective depletion of individual effector subsets, commonly used to identify correlates of protective immunity, has uncovered redundancies, but also cooperative mechanisms, between different arms of the adaptive immune response (19, 20, 44, 46, 47). During virus infections typically establishing persistence, the interactions between distinct immune components may be critical in the survival of the host. Thus, acute JHMV infection of the CNS is primarily controlled by CD8+ T cells (21). However, CD4+ T cell help enhances CD8+ T cell expansion, effector function, and survival (22). Neutralizing Ab emerges following clearance of infectious virus (29), but T cells are also maintained within the CNS (24, 34). The long-term inability of T cells to control infection in µMT mice, despite initial clearance of infectious virus, revealed the protective role of humoral immunity during persistence (17). The fact that infusion of polyclonal JHMV Ab at the time of initial clearance effectively controlled recrudescence (17) suggested that T cells may be redundant after reducing infectious virus to undetectable levels. Precedence for suppression of persisting virus in the CNS by prolonged intrathecal Ab synthesis by B cells within the CNS is provided by control of alphavirus encephalomyelitis (20).

The reactivity of virus-specific T cells was examined to determine the fate of initially protective CD8+ T cells during viral recrudescence in µMT mice. The CNS of µMT mice contained comparable numbers of CD8+ T cells relative to wt mice, but surprisingly lower frequencies of virus-specific CD8+ T cells throughout the entire course of infection. In addition, severely compromised cytolytic function by µMT-derived CMC during the acute response raises the question as to the mechanism which initially controls virus replication. Although perforin-mediated cytolysis clears virus from microglia and astrocytes (29), IFN-{gamma} acts as the dominant antiviral cytokine in oligodendrocytes (23). However, studies of pathogenesis in infected perforin- and IFN-{gamma}-deficient mice indicate that IFN-{gamma} plays a more prominent role in protection (23, 29). By contrast, Fas-Fas ligand interactions do not contribute to viral clearance or pathogenesis (51). Initial viral clearance in µMT mice may thus be predominantly controlled by antiviral IFN-{gamma} rather than perforin-mediated cytolysis. An ineffective cytolytic response in vivo is supported by the similar distribution of viral Ag during viral recrudescence compared with acute infection, i.e., in microglia, astrocytes, and oligodendrocytes (17). Nevertheless, impaired cytotoxicity is not intrinsic to µMT-derived CD8+ T cells, as cytolytic function is readily restored upon restimulation with infected wt splenocytes in vitro (17). Furthermore, a pronounced defect in IFN-{gamma} secretion by µMT-derived CD8+ T cells was inapparent taking the overall lower frequencies of virus-specific CD8+ T cells into account. This is supported by high levels of IFN-{gamma} mRNA in the CNS of µMT mice (17), similar IFN-{gamma}+:tetramer+ T cell ratios, and only moderate reduction in IFN-{gamma} production as measured by intracellular staining (see Figs. 2Go and 6Go). Since NK cells constitute similar percentages of CMC from both groups of mice early during infection (4–5% at day 8 p.i.) and drop below detection by day 14 p.i. (data not shown), they are not believed to contribute significantly to altered pathogenesis in µMT mice. Initial viral clearance in µMT mice, despite reduced T cell effector function, suggests that the response in wt mice by far surpasses a minimal threshold required for antiviral control. Nevertheless, this apparently excessive response may be critical in prolonging viral control and limiting virus spread within the CNS until the emergence of protective Ab.

Reduced primary virus-specific T cell responses in the absence of B cells were not evident following a number of other virus infections (7, 8, 10, 11, 14). Effector function of virus-specific CD8+ T cells, as well as CD8+ memory populations (10, 13), and frequencies of virus-specific memory CD4+ T cells (11) were not altered significantly in µMT mice compared with wt mice. However, impaired antiviral T cell function in µMT mice was suggested by the inability of adoptively transferred T cells primed in these mice to control LCMV infection (16). A reduced capacity of splenocytes from LCMV-immune µMT mice to secrete both IL-2 and IFN-{gamma}, but not reduced frequencies of Ag-specific T cells, contrasts sharply with reduced virus-specific CD4+ and CD8+ T cells but no significant reduction in IFN-{gamma} production observed during JHMV infection. The reasons underlying impaired T cell function in JHMV-infected µMT mice compared with other viral infections is unclear. Ineffective recruitment of T cells into the CNS can be ruled out because total percentages of CD4+ and CD8+ T cells are similar in the CNS of wt and µMT mice. Reduced frequencies of virus-specific CD8+ T cells in both spleen and CLN during the acute response rather implicates inefficient priming/expansion. The fact that CD4+ T cell expansion is also severely limited in infected µMT mice suggests that reduced CD4+ T cell help diminishes CD8+ T cell expansion and differentiation. CD4+ T cell responsiveness was also decreased in B cell-deficient mice early during ocular HSV infection (52), and expansion, but not function, was also impaired in CD4+ T cells from µMT mice immunized with keyhole limpet hemocyanin (53, 54). The defects in keyhole limpet hemocyanin-responding T cells were attributed to ineffective Ag presentation due to the lack of immune complex formation (54). Nevertheless, B cells appear to provide a more critical component than CD4+ Th cells in regulating CD8+ T cell expansion during JHMV infection, as virus-specific CD8+ T cells in peripheral lymphoid organs as well as in CMC were more severely reduced in the absence of B cells than in CD4+ T cell-depleted mice. Efforts to enhance T cell responsiveness via transfer of B cells from naive mice to µMT recipients failed. No differences in virus-specific CD4+ or CD8+ T cells frequencies were evident 5 or 8 days p.i. in these recipients compared with untreated µMT mice (data not shown). B cell transfers also had no effect on virus titers in the CNS at days 5 or 8 p.i. (data not shown). The degree to which the absence of B cells or Ab alone, the lack of CD4+ T cell-B cell interactions, or inhibited follicle formation and disrupted lymphoid architecture in µMT mice contribute to CD8+ T cell expansion therefore remains unclear.

Exclusive neurotropism of JHMV may compound inefficient Ag-specific CD4+ and CD8+ T cell expansion in JHMV-infected µMT mice. Although the CNS is efficient in supporting secondary activation of primed T cells, it is poor in priming naive T cells (49, 50, 55). T cell priming during a parenchymal CNS infection is believed to take place in peripheral lymphoid organs where B cells may contribute to activation. The absence of B cell follicle formation is associated with reduced follicular dendritic cell networks in µMT mice and diminished spleen and CLN cellularity (11). Thus, the restricted nature of JHMV replication in the CNS, coincident with limited peripheral Ag presentation, may render T cell activation more dependent on a component provided by B cells compared with other viral infections previously studied. However, perturbed T cell expansion even following peripheral JHMV immunization suggested a mechanism involving Ag presentation rather than CNS infection as responsible for diminished T cell responsiveness. There is no evidence that B cells themselves act as APC during JHMV infection. However, an indirect regulatory role for B cells during priming cannot be ruled out. Although a role for Ab and complement in enhancing Ag presentation in wt mice via sequestration of immune complexes to the spleen cannot be ruled out (43, 54), there was no evidence for enhanced splenic vs CLN priming in wt mice compared with µMT mice (Fig. 4Go). The observation that JHMV replication in µMT mice follows similar kinetics and never exceeds titers in wt mice also negates a role of immune complexes in delaying CNS infection. Interestingly, a significant contribution of B cells to effector CD8+ T cells was recently uncovered in the clearance of, and recovery from, influenza virus infection (56). However, in contrast to JHMV infection, the as yet unidentified B cell activity was Th cell independent and did not appear to enhance CD8+ T cell function. Furthermore, the lack of Th cell-B cell interaction may indirectly dysregulate APC function. B cells have indeed been shown to affect dendritic cell function by regulating cytokine production. Upon Ag stimulation, dendritic cells from µMT mice produce higher levels of IL-12p70 and fail to induce IL-4 secretion, resulting in potential CD4+ Th1 cell deviation (57). Although there is no evidence for this pathway during JHMV infection, alternative default interactions of CD4+ T cells with APC rather than B cells may conceivably result in diminished T cell activation.

In summary, the data indicate that not only the lack of Ab, but severely reduced frequencies of virus-specific T cells contribute to viral recrudescence in the CNS of µMT mice. Impaired CD4+ and CD8+ T cell expansion appears to be unique to JHMV infection of the CNS parenchyma and results in reduced T cell effector function within the CNS. Although the limited T cell response is sufficient to reduce viral replication, virus is not cleared below detection and recrudesces. Premature loss of effector function below a minimal threshold may thus provide a window for virus reactivation. An inability to replenish effector cells concomitant with increasing Ag load in the CNS appears to ultimately lead to exhaustion. Reduced numbers of splenic T cells in µMT mice (10, 11) and inadequate CD4+ T cell help may facilitate this process, analogous to high-dose LCMV-induced loss of specific CD8+ T cells (1, 2, 3, 7). Thus, a vigorous early T cell response may tip the balance between viral replication and immunity to viral persistence, which is ultimately controlled by Ab.


    Footnotes
 
1 This work was supported by National Institutes of Health Grants NS 18146 and AI 33314. Back

2 Address correspondence and reprint requests to Dr. Cornelia C. Bergmann, 1333 San Pablo Street, MCH 142, Los Angeles, CA 90033. E-mail address: cbergman{at}hsc.usc.edu Back

3 Abbreviations used in this paper: wt, wild type; CLN, cervical lymph node; CMC, CNS-derived mononuclear cells; JHMV, JHM strain of mouse hepatitis virus; LCMV, lymphocytic choriomeningitis virus; p.i., postinfection. Back

Received for publication February 2, 2001. Accepted for publication May 30, 2001.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Moskophidis, D., F. Lechner, H. Pircher, R. M. Zinkernagel. 1993. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 362:758.[Medline]
  2. Gallimore, A., A. Glithero, A. Godkin, A. C. Tissot, A. Pluckthun, T. Elliott, H. Hengartner, R. Zinkernagel. 1998. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J. Exp. Med. 187:1383.[Abstract/Free Full Text]
  3. Zajac, A. J., J. N. Blattman, K. Murali-Krishna, D. J. D. Sourdive, M. Suresh, J. D. Altman, R. Ahmed. 1998. Viral immune evasion due to persistence of activated cells without effector function. J. Exp. Med. 188:2205.[Abstract/Free Full Text]
  4. Oxenius, A., R. M. Zinkernagel, H. Hengartner. 1998. Comparison of activation versus induction of unresponsiveness of virus-specific CD4+ and CD8+ T cells upon acute versus persistent viral infection. Immunity 9:449.[Medline]
  5. Rehermann, B., K. M. Chang, J. McHutchinson, R. Kokka, M. Houghton, C. M. Rice, C. F. V.. 1996. Differential cytotoxic T-lymphocyte responsiveness to hepatitis B and C viruses in chronically infected patients. J. Virol. 70:7092.[Abstract/Free Full Text]
  6. Carmichael, A., X. Jin, P. Sissons, L. Borysiewicz. 1993. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J. Exp. Med. 177:249.[Abstract/Free Full Text]
  7. Thomsen, A. R., J. Johansen, O. Marker, J. P. Christensen. 1996. Exhaustion of CTL memory and recrudescence of viremia in lymphocytic choriomeningitis virus-infected MHC class II-deficient mice and B cell-deficient mice. J. Immunol. 157:3074.[Abstract]
  8. Planz, O., S. Ehl, E. Furrer, E. Horvath, M. A. Bründler, H. Hengartner, R. M. Zinkernagel. 1997. A critical role for neutralizing-antibody-producing B cells, CD4+ T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers. Proc. Natl. Acad. Sci. USA 94:6874.[Abstract/Free Full Text]
  9. Kitamura, D., J. Roes, R. Kuhn, K. Rajewsky. 1991. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin µ chain gene. Nature 350:423.[Medline]
  10. Asano, M. S., R. Ahmed. 1996. CD8 T cell memory in B cell-deficient mice. J. Exp. Med. 183:2165.[Abstract/Free Full Text]
  11. Topham, D. J., R. A. Tripp, A. M. Hamilton-Easton, S. R. Sarawar, P. C. Doherty. 1996. Quantitative analysis of the influenza virus-specific CD4+ T cell memory in the absence of B cells and Ig. J. Immunol. 157:2947.[Abstract]
  12. Mozdzanowska, K., M. Furchner, K. Maiese, W. Gerhard. 1997. CD4+ T cells are ineffective in clearing a pulmonary infection with influenza type A virus in the absence of B cells. Virology 239:217.[Medline]
  13. Bründler, M. A., P. Aichele, M. Bachmann, D. Kitamura, K. Rajewsky, R. M. Zinkernagel. 1996. Immunity to viruses in B cell-deficient mice: influence of antibodies on virus persistence and on T cell memory. Eur. J. Immunol. 26:2257.[Medline]
  14. Jonjic, S., I. Pavic, B. Polic, I. Crnkovic, P. Lucin, U. H. Koszinowski. 1994. Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. J. Exp. Med. 179:1713.[Abstract/Free Full Text]
  15. Epstein, S. L., C.-Y. Lo, J. A. Misplon, J. R. Bennink. 1998. Mechanism of protective immunity against influenza virus infection in mice without antibodies. J. Immunol. 160:322.[Abstract/Free Full Text]
  16. Homann, D., A. Tishon, D. P. Berger, W. O. Weigle, M. G. von Herrath, M. B. A. Oldstone. 1998. Evidence of an underlying CD4 helper and CD8 T-cell defect in B-cell-deficient mice: failure to clear persistent virus infection after adoptive immunotherapy with virus-specific memory cells from µMT/µMT mice. J. Virol. 72:9208.[Abstract/Free Full Text]
  17. Lin, M. T., D. R. Hinton, N. W. Marten, C. C. Bergmann, S. A. Stohlman. 1999. Antibody prevents virus reactivation within the central nervous system. J. Immunol. 162:7358.[Abstract/Free Full Text]
  18. Beland, J. L., R. A. Sobel, H. Adler, N. C. Del-Pan, I. J. Rimm. 1999. B cell deficient mice have increased susceptibility to HSV-1 encephalomyelitis and mortality. J. Neuroimmunol. 94:122.[Medline]
  19. Sanna, P. P., D. R. Burton. 2000. Role of antibodies in controlling viral disease: lessons from experiments of nature and gene knockouts. J. Virol. 74:9813.[Free Full Text]
  20. Griffin, D., B. Levine, W. Tyor, S. Ubol, P. Despres. 1997. The role of antibody in recovery from alphavirus encephalitis. Immunol. Rev. 159:155.[Medline]
  21. Stohlman, S. A., C. Bergmann, R. van der Veen, D. Hinton. 1995. Mouse hepatitis virus-specific cytotoxic T lymphocytes protect from lethal infection without eliminating virus from oligodendroglia. J. Virol. 69:684.[Abstract]
  22. Stohlman, S. A., C. C. Bergmann, D. Cua, M. Lin, S. Ho, D. Hinton. 1998. CTL effector function within the central nervous system requires CD4+ T cells. J. Immunol. 160:2896.[Abstract/Free Full Text]
  23. Parra, B., D. R. Hinton, N. W. Marten, C. C. Bergmann, M. T. Lin, C. S. Yang, S. A. Stohlman. 1999. IFN-{gamma} is required for viral clearance from central nervous system oligodendroglia. J. Immunol. 162:1641.[Abstract/Free Full Text]
  24. Bergmann, C. C., J. D. Altman, D. Hinton, S. A. Stohlman. 1999. Inverted immunodominance and impaired cytolytic function of CD8+ T cells during viral persistence in the CNS. J. Immunol. 163:3379.[Abstract/Free Full Text]
  25. Stohlman, S. A., C. C. Bergmann, S. Perlman. 1999. Mouse hepatitis virus. R. Ahmed, and I. Chen, eds. Persistent Viral Infections 537. Wiley, New York.
  26. Lane, T. E., M. J. Buchmeier. 1997. Murine coronavirus infection: a paradigm for virus-induced demyelinating disease. Trends Microbiol. 1:9.
  27. Adami, C., J. Pooley, J. Glomb, E. Stecker, F. Fazal, J. O. Fleming, S. C. Baker. 1995. Evolution of mouse hepatitis virus (MHV) during chronic infection: quasispecies nature of the persisting MHV RNA. Virology 209:337.[Medline]
  28. Bergmann, C., E. Dimacali, S. Stohl, W. Wei, M. M. C. Lai, S. Tahara, N. Marten. 1998. Variability of persisting MHV RNA sequences comprising immune and replication relevant domains. Virology 244:563.[Medline]
  29. Lin, M. T., S. A. Stohlman, D. R. Hinton. 1997. Mouse hepatitis virus is cleared from the central nervous system of mice lacking perforin-mediated cytolysis. J. Virol. 71:383.[Abstract]
  30. Fleming, J. O., M. Trousdale, F. E. Zactarim, S. A. Stohlman, L. P. Weiner. 1986. Pathogenicity of antigenic variants of murine coronavirus JHM selected with mAb. J. Virol. 58:869.[Abstract/Free Full Text]
  31. Stohlman, S. A., P. R. Brayton, J. O. Fleming, L. P. Weiner, M. C. Lai. 1982. Murine coronaviruses: isolation and characterization of two plaque morphology variants of the JHM neurotropic strain. J. Gen. Virol. 63:265.[Abstract/Free Full Text]
  32. Williamson, J. S. P., S. A. S. Stohlman. 1990. Effective clearance of mouse hepatitis virus from the CNS requires both CD4+ and CD8+ T cells. J. Virol. 64:4590.
  33. Marten, N. W., S. A. Stohlman, W. Smith-Begolka, S. D. Miller, E. Dimicali, Q. Yao, S. Stohl, J. Goverman, C. C. Bergmann. 1999. Selection of CD8+ cells with highly focused specificity during viral persistence in the central nervous system. J. Immunol. 162:3905.[Abstract/Free Full Text]
  34. Marten, N. W., S. A. Stohlman, C. C. Bergmann. 2000. Role of viral persistence in retaining CD8+ T cells within the CNS. J. Virol. 74:7903.[Abstract/Free Full Text]
  35. Stohlman, S. A., S. Kyuwa, J. M. Polo, D. Brady, M. C. Lai, C. C. Bergmann. 1993. Characterization of mouse hepatitis virus-specific cytotoxic T cells derived from the central nervous system of mice infected with the JHM strain. J. Virol. 67:7050.[Abstract/Free Full Text]
  36. Bergmann, C. C., M. McMillan, S. A. Stohlman. 1993. Characterization of the Ld-restricted cytotoxic T lymphocyte epitope in the mouse hepatitis virus nucleocapsid protein. J. Virol. 67:7041.[Abstract/Free Full Text]
  37. Bergmann, C. C., Q. Yao, M. Lin, S. A. Stohlman. 1996. The JHM strain of mouse hepatitis virus induces a spike protein-specific Db-restricted cytotoxic T cell response. J. Gen. Virol. 77:315.[Abstract/Free Full Text]
  38. Castro, R. F., S. Perlman. 1995. CD8+ T-cell epitopes within the surface glycoprotein of a neurotropic coronavirus and correlation with pathogenicity. J. Virol. 69:8127.[Abstract]
  39. Xue, S., S. Perlman. 1997. Antigen specificity of CD4 T cell response in the central nervous system of mice infected with mouse hepatitis virus. Virology 238:68.[Medline]
  40. Ahmed, R., D. Gray. 1996. Immunological memory and protective immunity: understanding their relation. Science 272:54.[Abstract]
  41. Harrington, L. E., M. Galvan, L. Baum, J. D. Altman, R. Ahmed. 2000. Differentiating between memory and effector CD8 T cells by altered expression of cell surface O-glycans. J. Exp. Med. 191:1241.[Abstract/Free Full Text]
  42. Doherty, P. C., J. Allen, F. Lynch, R. Ceredig. 1990. Dissection of an inflammatory process induced by CD8 T cells. Immunol. Today 11:55.[Medline]
  43. Ochsenbein, A. F., R. M. Zinkernagel. 2000. Natural antibodies and complement link innate and acquired immunity. Immunol. Today 21:624.[Medline]
  44. Koszinowski, U. H., M. Reddehase, S. Jonjic. 1991. The role of CD4 and CD8 T cells in viral infection. Curr. Opin. Immunol. 3:471.[Medline]
  45. Matloubian, M., R. J. Conception, R. Ahmed. 1994. CD4+ T cells are required to sustain CD8+ cytotoxic T cell responses during chronic viral infection. J. Virol. 68:8056.[Abstract/Free Full Text]
  46. Altfeld, M., E. S. Rosenberg. 2000. The role of CD4+ T helper cells in the cytotoxic T lymphocyte response to HIV-1. Curr. Opin. Immunol. 12:375.[Medline]
  47. Doherty, P. C., D. J. Topham, R. A. Tripp, R. D. Cardin, J. W. Brooks, P. G. Stevenson. 1997. Effector CD4 and CD8 T cell mechanisms in the control of respiratory infections. Immunol. Rev. 159:105.[Medline]
  48. Roth, R., M. J. Mamula. 1997. Trafficking of adoptively transferred B lymphocytes in B-lymphocyte-deficient mice. J. Exp. Biol. 200:2057.[Abstract]
  49. Cserr, H. F., P. M. Knopf. 1997. Cervical lymphatics, the blood brain barrier, and the immunoreactivity of the brain. R. W. Keane, and W. F. Hickey, eds. Immunology of the Central Nervous System 134. Oxford Univ. Press, Oxford.
  50. Sedgwick, J. D., W. F. Hickey. 1997. Antigen presentation in the central nervous system. R. W. Keane, and W. F. Hickey, eds. Immunology of the Central Nervous System 364. Oxford Univ. Press, Oxford.
  51. Parra, B., M. T. Lin, S. A. Stohlman, C. C. Bergmann, R. Atkinson, D. A. Hinton. 2000. Fas-Fas ligand interactions do not contribute to the pathogenesis of mouse hepatitis virus in the central nervous system. J. Virol. 74:2447.[Abstract/Free Full Text]
  52. Deshpande, S. P., M. Zheng, M. Daheshia, B. T. Rouse. 2000. Pathogenesis of herpes simplex virus-induced ocular immunoinflammatory lesions in B-cell-deficient mice. J. Virol. 74:3517.[Abstract/Free Full Text]
  53. Linton, P.-J., J. Harbertson, L. M. Bradley. 2000. A critical role of B cells in the development of memory CD4 cells. J. Immunol. 165:5558.[Abstract/Free Full Text]
  54. Hamano, Y., A. Hisashi, H. Saisho, T. Saito. 2000. Immune complex and Fc receptor-mediated augmentation of antigen presentation for in vivo Th cell responses. J. Immunol. 164:6113.[Abstract/Free Full Text]
  55. Stevenson, P. G., S. Freeman, C. R. M. Bangham, S. Hawke. 1997. Virus dissemination through the brain parenchyma without immunologic control. J. Immunol. 159:1876.[Abstract]
  56. Mozdzanowska, K., K. Maiese, W. Gerhard. 2000. Th cell-deficient mice control influenza virus infection more effectively than Th- and B cell-deficient mice: evidence for a Th-independent contribution by B cells to virus clearance. J. Immunol. 164:2635.[Abstract/Free Full Text]
  57. Moulin, V., F. Andris, K. Thielemans, C. Maliszewski, J. Urbain, M. Moser. 2000. B lymphocytes regulate dendritic cell (DC) function in vivo: increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type 1 deviation. J. Exp. Med. 192:47.



This article has been cited by other articles:


Home page
J. Virol.Home page
J. N. Blattman, E. J. Wherry, S.-J. Ha, R. G. van der Most, and R. Ahmed
Impact of Epitope Escape on PD-1 Expression and CD8 T-Cell Exhaustion during Chronic Infection
J. Virol., May 1, 2009; 83(9): 4386 - 4394.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Nozaki, J. M. Rosenblum, D. Ishii, K. Tanabe, and R. L. Fairchild
CD4 T Cell-Mediated Rejection of Cardiac Allografts in B Cell-Deficient Mice
J. Immunol., October 15, 2008; 181(8): 5257 - 5263.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
N. S. Butler, A. A. Dandekar, and S. Perlman
Antiviral Antibodies Are Necessary To Prevent Cytotoxic T-Lymphocyte Escape in Mice Infected with a Coronavirus
J. Virol., December 15, 2007; 81(24): 13291 - 13298.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
H. M. Ashour and T. M. Seif
The role of B cells in the induction of peripheral T cell tolerance
J. Leukoc. Biol., November 1, 2007; 82(5): 1033 - 1039.
[Full Text] [PDF]


Home page
J. Virol.Home page
R. Burdeinick-Kerr, J. Wind, and D. E. Griffin
Synergistic Roles of Antibody and Interferon in Noncytolytic Clearance of Sindbis Virus from Different Regions of the Central Nervous System
J. Virol., June 1, 2007; 81(11): 5628 - 5636.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. K. Mann, K. Maresz, L. P. Shriver, Y. Tan, and B. N. Dittel
B Cell Regulation of CD4+CD25+ T Regulatory Cells and IL-10 Via B7 is Essential for Recovery From Experimental Autoimmune Encephalomyelitis
J. Immunol., March 15, 2007; 178(6): 3447 - 3456.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. AbuAttieh, M. Rebrovich, P. J. Wettstein, Z. Vuk-Pavlovic, A. H. Limper, J. L. Platt, and M. Cascalho
Fitness of Cell-Mediated Immunity Independent of Repertoire Diversity
J. Immunol., March 1, 2007; 178(5): 2950 - 2960.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
R. Burrer, M. J. Buchmeier, T. Wolfe, J. P.C. Ting, R. Feuer, A. Iglesias, and M. G. von Herrath
Exacerbated Pathology of Viral Encephalitis in Mice with Central Nervous System-Specific Autoantibodies
Am. J. Pathol., February 1, 2007; 170(2): 557 - 566.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. E. Lund, M. Hollifield, K. Schuer, J. L. Lines, T. D. Randall, and B. A. Garvy
B Cells Are Required for Generation of Protective Effector and Memory CD4 Cells in Response to Pneumocystis Lung Infection
J. Immunol., May 15, 2006; 176(10): 6147 - 6154.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Diaz-de-Durana, G. T. Mantchev, R. J. Bram, and A. Franco
TACI-BLyS signaling via B-cell-dendritic cell cooperation is required for naive CD8+ T-cell priming in vivo
Blood, January 15, 2006; 107(2): 594 - 601.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
S. Cepok, B. Rosche, V. Grummel, F. Vogel, D. Zhou, J. Sayn, N. Sommer, H.-P. Hartung, and B. Hemmer
Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis
Brain, July 1, 2005; 128(7): 1667 - 1676.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Y. V. Mendez-Fernandez, M. J. Hansen, M. Rodriguez, and L. R. Pease
Anatomical and Cellular Requirements for the Activation and Migration of Virus-Specific CD8+ T Cells to the Brain during Theiler's Virus Infection
J. Virol., March 1, 2005; 79(5): 3063 - 3070.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. C. Bergmann, B. Parra, D. R. Hinton, C. Ramakrishna, K. C. Dowdell, and S. A. Stohlman
Perforin and Gamma Interferon-Mediated Control of Coronavirus Central Nervous System Infection by CD8 T Cells in the Absence of CD4 T Cells
J. Virol., February 15, 2004; 78(4): 1739 - 1750.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
M. S. Diamond, E. M. Sitati, L. D. Friend, S. Higgs, B. Shrestha, and M. Engle
A Critical Role for Induced IgM in the Protection against West Nile Virus Infection
J. Exp. Med., December 15, 2003; 198(12): 1853 - 1862.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. Ugrinovic, N. Menager, N. Goh, and P. Mastroeni
Characterization and Development of T-Cell Immune Responses in B-Cell-Deficient (Igh-6-/-) Mice with Salmonella enterica Serovar TyphimuriumInfection
Infect. Immun., December 1, 2003; 71(12): 6808 - 6819.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. P. Christensen, S. O. Kauffmann, and A. R. Thomsen
Deficient CD4+ T Cell Priming and Regression of CD8+ T Cell Functionality in Virus-Infected Mice Lacking a Normal B Cell Compartment
J. Immunol., November 1, 2003; 171(9): 4733 - 4741.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. P. Simmons, S. Clare, M. Ghaem-Maghami, T. K. Uren, J. Rankin, A. Huett, R. Goldin, D. J. Lewis, T. T. MacDonald, R. A. Strugnell, et al.
Central Role for B Lymphocytes and CD4+ T Cells in Immunity to Infection by the Attaching and Effacing Pathogen Citrobacter rodentium
Infect. Immun., September 1, 2003; 71(9): 5077 - 5086.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Ramakrishna, C. C. Bergmann, R. Atkinson, and S. A. Stohlman
Control of Central Nervous System Viral Persistence by Neutralizing Antibody
J. Virol., April 15, 2003; 77(8): 4670 - 4678.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. S. Diamond, B. Shrestha, A. Marri, D. Mahan, and M. Engle
B Cells and Antibody Play Critical Roles in the Immediate Defense of Disseminated Infection by West Nile Encephalitis Virus
J. Virol., February 15, 2003; 77(4): 2578 - 2586.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
N. W. Marten, S. A. Stohlman, J. Zhou, and C. C. Bergmann
Kinetics of Virus-Specific CD8+-T-Cell Expansion and Trafficking following Central Nervous System Infection
J. Virol., February 15, 2003; 77(4): 2775 - 2778.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S.-I. Tschen, C. C. Bergmann, C. Ramakrishna, S. Morales, R. Atkinson, and S. A. Stohlman
Recruitment Kinetics and Composition of Antibody-Secreting Cells Within the Central Nervous System Following Viral Encephalomyelitis
J. Immunol., March 15, 2002; 168(6): 2922 - 2929.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bergmann, C. C.
Right arrow Articles by Stohlman, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bergmann, C. C.
Right arrow Articles by Stohlman, S. A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS